Clemens Grupp
Overview
Explore the profile of Clemens Grupp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kouidi E, Hanssen H, Anding-Rost K, Cupisti A, Deligiannis A, Grupp C, et al.
Eur J Prev Cardiol
. 2024 Apr;
31(12):1493-1515.
PMID: 38593202
Cardiovascular (CV) morbidity and mortality is high in patients with chronic kidney disease (CKD). Most patients reveal a high prevalence of CV risk factors such as diabetes or arterial hypertension...
2.
Grupp C
Z Gerontol Geriatr
. 2021 Feb;
54(3):217-222.
PMID: 33629129
The prevalence of frailty is very high in patients with chronic renal insufficiency and increases with its severity. A number of factors associated with chronic renal insufficiency appear to favor...
3.
Grupp C, Beckermann J, Koster E, Zewinger S, Knittel M, Walek T, et al.
Blood Purif
. 2020 Mar;
49(4):457-467.
PMID: 32191938
Background: Severe hypertriglyceridemia (HTG) is associated with major complications such as acute or relapsing pancreatitis (AP) and atherosclerotic cardiovascular disease (ASCVD). Rapid elimination of triglyceride (TG)-rich lipoproteins (LP) with double...
4.
Grupp C, Troche-Polzien I, Stock J, Bramlage C, Muller G, Koziolek M
PLoS One
. 2019 Sep;
14(9):e0222102.
PMID: 31539375
Objective: Thrombophilic risk factors (TRFs) occur rather frequently in hemodialysis (HD) patients. However, little is known about their significance in HD patients, besides their potential impact on arteriovenous (AV) access...
5.
Delistefani F, Wallbach M, Muller G, Koziolek M, Grupp C
BMC Nephrol
. 2019 Jun;
20(1):199.
PMID: 31151433
Background: Due to rising vascular comorbidities of patients undergoing dialysis, the prevalence of permanent hemodialysis catheters as hemodialysis access is increasing. However, infection is a major complication of these catheters....
6.
Hammer F, Malzahn U, Donhauser J, Betz C, Schneider M, Grupp C, et al.
Kidney Int
. 2019 Feb;
95(4):983-991.
PMID: 30712923
Mineralocorticoid receptor antagonists have beneficial effects on left ventricular remodeling, cardiac fibrosis, and arrhythmia in heart failure, but efficacy and safety in dialysis patients is less clear. We evaluated the...
7.
Strutz F, Grupp C
Dtsch Med Wochenschr
. 2018 May;
143(11):802-805.
PMID: 29807380
No abstract available.
8.
Grupp C, Koziolek M, Wallbach M, Hoxhold K, Muller G, Bramlage C
J Clin Hypertens (Greenwich)
. 2018 Feb;
20(3):582-588.
PMID: 29450973
Detection of renal artery stenosis (RAS) using Doppler is difficult to evaluate, particularly under conditions such as bilateral RAS or difficultly accessible renal arteries (RA). The objective of the present...
9.
Bramlage C, Froelich B, Wallbach M, Minguet J, Grupp C, Deutsch C, et al.
Rheumatol Int
. 2017 Feb;
37(4):599-605.
PMID: 28214923
The risk of infection in patients with rheumatic diseases is elevated, but a clear marker to differentiate the cause of the systemic inflammation is missing. We assessed the ability urinary...
10.
Bramlage C, Froelich B, Wallbach M, Minguet J, Grupp C, Deutsch C, et al.
Clin Rheumatol
. 2016 Oct;
35(12):2939-2946.
PMID: 27734231
In patients with rheumatic diseases, reliable markers for determining disease activity are scarce. One potential parameter is the level of immunoglobulin free light chains (FLCs), which is known to be...